BLAST table : MUP_00080
accession | DB | alignment | Evalue | Score | Ident. | link | product | gene | organism | ec | |
---|---|---|---|---|---|---|---|---|---|---|---|
1 |
Q6MZ96_MYCUA (Q6MZ96) |
2e-99 | 365 | 100% | Possible nucleic acid binding protein | MUP008c | Mycobacterium ulcerans (strain Agy99) | ||||
2 |
B6CLQ1_MYCMR (B6CLQ1) |
3e-97 | 357 | 98% | Nucleic acid binding protein | MUDP_063 | Mycobacterium marinum DL240490 | ||||
3 |
B6CLU9_9MYCO (B6CLU9) |
1e-90 | 335 | 98% | Nucleic acid binding protein | MULP_011 | Mycobacterium liflandii 128FXT | ||||
4 |
D5P1L8_9MYCO (D5P1L8) |
5e-29 | 131 | 56% | Transcription elongation factor NusA | nusA2 HMPREF0591_0062 |
Mycobacterium parascrofulaceum ATCC BAA-614 | ||||
5 |
Q1QEP6_PSYCK (Q1QEP6) |
1e-21 | 107 | 38% | NusA antitermination factor | Pcryo_0073 | Psychrobacter cryohalolentis (strain K5) | ||||
6 |
Q4FVL6_PSYA2 (Q4FVL6) |
1e-21 | 106 | 38% | NusA antitermination factor | nusA Psyc_0068 |
Psychrobacter arcticus (strain DSM 17307 / 273-4) | ||||
7 |
F5SQ74_9GAMM (F5SQ74) |
1e-21 | 106 | 39% | N utilization substance A | nusA HMPREF9373_1207 |
Psychrobacter sp. 1501 2011 |
||||
8 |
A5WBS4_PSYWF (A5WBS4) |
2e-21 | 105 | 39% | NusA antitermination factor | PsycPRwf_0156 | Psychrobacter sp. (strain PRwf-1) | ||||
9 |
D5V8Y7_MORCR (D5V8Y7) |
3e-21 | 105 | 38% | Transcription termination/antitermination protein NusA | nusA MCR_1769 |
Moraxella catarrhalis (strain RH4) | ||||
10 |
F1XHI1_MORCA (F1XHI1) |
3e-21 | 105 | 38% | Transcription elongation factor NusA | nusA EA1_08337 |
Moraxella catarrhalis O35E | ||||
11 |
F1XC11_MORCA (F1XC11) |
3e-21 | 105 | 38% | Transcription elongation factor NusA | nusA E9W_08255 |
Moraxella catarrhalis CO72 | ||||
12 |
F1X7F2_MORCA (F1X7F2) |
3e-21 | 105 | 38% | Transcription elongation factor NusA | nusA E9U_09410 |
Moraxella catarrhalis BC8 | ||||
13 |
F1X0E7_MORCA (F1X0E7) |
3e-21 | 105 | 38% | Transcription elongation factor NusA | nusA E9S_06268 |
Moraxella catarrhalis BC7 | ||||
14 |
F1WS91_MORCA (F1WS91) |
3e-21 | 105 | 38% | Transcription elongation factor NusA | nusA E9Q_01311 |
Moraxella catarrhalis BC1 | ||||
15 |
F1WM56_MORCA (F1WM56) |
3e-21 | 105 | 38% | Transcription elongation factor NusA | nusA E9O_01039 |
Moraxella catarrhalis 12P80B1 | ||||
16 |
F1WGE6_MORCA (F1WGE6) |
3e-21 | 105 | 38% | Transcription elongation factor NusA | nusA E9M_00053 |
Moraxella catarrhalis 46P47B1 | ||||
17 |
F1WDD5_MORCA (F1WDD5) |
3e-21 | 105 | 38% | Transcription elongation factor NusA | nusA E9K_04717 |
Moraxella catarrhalis 103P14B1 | ||||
18 |
F1WAN5_MORCA (F1WAN5) |
3e-21 | 105 | 38% | Transcription elongation factor NusA | nusA E9G_09365 |
Moraxella catarrhalis 7169 | ||||
19 |
F1VR75_MORCA (F1VR75) |
3e-21 | 105 | 38% | Transcription elongation factor NusA | nusA E9Y_05115 |
Moraxella catarrhalis 101P30B1 | ||||
20 |
Q9HV54_PSEAE (Q9HV54) |
3e-21 | 105 | 38% | N utilization substance protein A | nusA PA4745 |
Pseudomonas aeruginosa | ||||
21 |
Q02FS7_PSEAB (Q02FS7) |
3e-21 | 105 | 38% | N utilization substance protein A | nusA PA14_62770 |
Pseudomonas aeruginosa (strain UCBPP-PA14) | ||||
22 |
B7V1F7_PSEA8 (B7V1F7) |
3e-21 | 105 | 38% | N utilization substance protein A | nusA PLES_51301 |
Pseudomonas aeruginosa (strain LESB58) | ||||
23 |
A6VCK2_PSEA7 (A6VCK2) |
3e-21 | 105 | 38% | N utilization substance protein A | nusA PSPA7_5463 |
Pseudomonas aeruginosa (strain PA7) | ||||
24 |
F5KHG2_PSEAE (F5KHG2) |
3e-21 | 105 | 38% | Transcription elongation factor NusA | nusA PA15_06355 |
Pseudomonas aeruginosa 152504 | ||||
25 |
F5K2B8_PSEAE (F5K2B8) |
3e-21 | 105 | 38% | Transcription elongation factor NusA | nusA PA13_11049 |
Pseudomonas aeruginosa 138244 | ||||
26 |
E3A033_PSEAE (E3A033) |
3e-21 | 105 | 38% | N utilization substance protein A | PA39016_002040023 | Pseudomonas aeruginosa 39016 | ||||
27 |
A3LK13_PSEAE (A3LK13) |
3e-21 | 105 | 38% | N utilization substance protein A | PA2G_05207 | Pseudomonas aeruginosa 2192 | ||||
28 |
A3L3D0_PSEAE (A3L3D0) |
3e-21 | 105 | 38% | N utilization substance protein A | PACG_04670 | Pseudomonas aeruginosa C3719 | ||||
29 |
A4CDB9_9GAMM (A4CDB9) |
4e-21 | 105 | 38% | Transcription elongation factor NusA | PTD2_16022 | Pseudoalteromonas tunicata D2 | ||||
30 |
C8NBH4_9GAMM (C8NBH4) |
5e-21 | 104 | 40% | N utilization substance A | nusA HMPREF0198_1852 |
Cardiobacterium hominis ATCC 15826 | ||||
31 |
D5CRY2_SIDLE (D5CRY2) |
8e-21 | 103 | 39% | NusA antitermination factor | Slit_1481 | Sideroxydans lithotrophicus (strain ES-1) | ||||
32 |
F7YM08_VIBAN (F7YM08) |
1e-20 | 103 | 37% | N utilization substance protein A | VAA_00803 | Vibrio anguillarum 775 | ||||
33 |
Q0HXR6_SHESR (Q0HXR6) |
1e-20 | 103 | 36% | NusA antitermination factor | Shewmr7_1090 | Shewanella sp. (strain MR-7) | ||||
34 |
Q0HLG2_SHESM (Q0HLG2) |
1e-20 | 103 | 36% | NusA antitermination factor | Shewmr4_1025 | Shewanella sp. (strain MR-4) | ||||
35 |
E6RPR6_PSEU9 (E6RPR6) |
1e-20 | 103 | 37% | Transcription elongation factor NusA | nusA PSM_A1066 |
Pseudoalteromonas sp. (strain SM9913) | ||||
36 |
Q8EHL6_SHEON (Q8EHL6) |
1e-20 | 103 | 36% | N utilization substance protein A | nusA SO_1203 |
Shewanella oneidensis | ||||
37 |
A0KTZ5_SHESA (A0KTZ5) |
2e-20 | 102 | 36% | NusA antitermination factor | Shewana3_1029 | Shewanella sp. (strain ANA-3) | ||||
38 |
F3BFR9_PSEHA (F3BFR9) |
2e-20 | 102 | 36% | Transcription termination protein NusA | nusA2 PH505_af00170 |
Pseudoalteromonas haloplanktis ANT/505 | ||||
39 |
Q3IJ54_PSEHT (Q3IJ54) |
2e-20 | 102 | 36% | Transcription elongation protein (N utilization substance protein A) (L factor) | nusA PSHAa0996 |
Pseudoalteromonas haloplanktis (strain TAC 125) | ||||
40 |
B6ENE1_ALISL (B6ENE1) |
2e-20 | 102 | 40% | Transcription elongation protein NusA | nusA VSAL_I0597 |
Aliivibrio salmonicida (strain LFI1238) Vibrio salmonicida (strain LFI1238) |
||||
41 |
Q2LWU5_SYNAS (Q2LWU5) |
2e-20 | 102 | 39% | Transcription elongation factor | SYNAS_26770 SYN_01789 |
Syntrophus aciditrophicus (strain SB) | ||||
42 |
A0Y311_9GAMM (A0Y311) |
2e-20 | 102 | 36% | Transcription elongation factor NusA | ATW7_05761 | Alteromonadales bacterium TW-7 | ||||
43 |
C9Q8P4_9VIBR (C9Q8P4) |
2e-20 | 102 | 37% | Transcription termination protein NusA | VCJ_002521 | Vibrio sp. RC341 | ||||
44 |
D9SFJ1_GALCS (D9SFJ1) |
2e-20 | 102 | 37% | NusA antitermination factor | Galf_1260 | Gallionella capsiferriformans (strain ES-2) Gallionella ferruginea capsiferriformans (strain ES-2) |
||||
45 |
D0HBP1_VIBMI (D0HBP1) |
3e-20 | 102 | 37% | Transcription termination protein NusA | VMA_000384 | Vibrio mimicus VM223 | ||||
46 |
D2YKW2_VIBMI (D2YKW2) |
3e-20 | 102 | 37% | N utilization substance protein A | nusA VMD_03960 |
Vibrio mimicus VM573 | ||||
47 |
D0IDC7_9VIBR (D0IDC7) |
3e-20 | 102 | 37% | Transcription termination protein NusA | VOA_003210 | Vibrio sp. RC586 | ||||
48 |
D0GT04_VIBMI (D0GT04) |
3e-20 | 102 | 37% | Transcription termination protein NusA | VII_003109 | Vibrio mimicus MB451 | ||||
49 |
D3RNU8_ALLVD (D3RNU8) |
3e-20 | 102 | 35% | NusA antitermination factor | Alvin_0501 | Allochromatium vinosum (strain ATCC 17899 / DSM 180 / NBRC 103801 / D) Chromatium vinosum |
||||
50 |
A4Y9C1_SHEPC (A4Y9C1) |
3e-20 | 102 | 36% | NusA antitermination factor | Sputcn32_2835 | Shewanella putrefaciens (strain CN-32 / ATCC BAA-453) | ||||
51 |
A1RGX4_SHESW (A1RGX4) |
3e-20 | 102 | 36% | NusA antitermination factor | Sputw3181_1069 | Shewanella sp. (strain W3-18-1) | ||||
52 |
A6D247_9VIBR (A6D247) |
3e-20 | 102 | 37% | Transcription elongation factor NusA | nusA VSAK1_10998 |
Vibrio shilonii AK1 | ||||
53 |
E6XJ87_SHEP2 (E6XJ87) |
3e-20 | 102 | 36% | NusA antitermination factor | Sput200_2978 | Shewanella putrefaciens (strain 200) | ||||
54 |
F7RJX4_9GAMM (F7RJX4) |
4e-20 | 102 | 36% | Transcription termination protein NusA | SOHN41_00931 | Shewanella sp. HN-41 | ||||
55 |
F2IPT9_VIBCH (F2IPT9) |
4e-20 | 102 | 37% | Transcription termination protein NusA | VCLMA_A0563 | Vibrio cholerae LMA3894-4 | ||||
56 |
C2INU4_VIBCH (C2INU4) |
4e-20 | 102 | 37% | Transcription termination protein NusA | VCB_000546 | Vibrio cholerae TMA 21 | ||||
57 |
C2I423_VIBCH (C2I423) |
4e-20 | 102 | 37% | Transcription termination protein NusA | VIF_001457 | Vibrio cholerae TM 11079-80 | ||||
58 |
C2HUU0_VIBCH (C2HUU0) |
4e-20 | 102 | 37% | Transcription termination protein NusA | VCA_002917 | Vibrio cholerae bv. albensis VL426 | ||||
59 |
C2CEM4_VIBCH (C2CEM4) |
4e-20 | 102 | 37% | Transcription termination protein NusA | VCG_003567 | Vibrio cholerae 12129 1 |
||||
60 |
A2P9U1_VIBCH (A2P9U1) |
4e-20 | 102 | 37% | N utilization substance protein A | nusA A55_0668 |
Vibrio cholerae 1587 | ||||
61 |
A1F705_VIBCH (A1F705) |
4e-20 | 102 | 37% | N utilization substance protein A | nusA VC274080_0723 |
Vibrio cholerae 2740-80 | ||||
62 |
D0HUX3_VIBCH (D0HUX3) |
4e-20 | 101 | 37% | Transcription termination protein NusA | VIH_000168 | Vibrio cholerae CT 5369-93 | ||||
63 |
E3I1L8_RHOVT (E3I1L8) |
4e-20 | 101 | 39% | NusA antitermination factor | Rvan_3198 | Rhodomicrobium vannielii (strain ATCC 17100 / ATH 3.1.1 / DSM 162 / LMG 4299) | ||||
64 |
F2GAC7_ALTMD (F2GAC7) |
4e-20 | 101 | 37% | Transcription elongation factor NusA | MADE_1008915 | Alteromonas macleodii (strain DSM 17117 / Deep ecotype) | ||||
65 |
D2YBM1_VIBMI (D2YBM1) |
4e-20 | 101 | 37% | N utilization substance protein A | nusA VMB_09180 |
Vibrio mimicus VM603 | ||||
66 |
Q9KU81_VIBCH (Q9KU81) |
4e-20 | 101 | 37% | N utilization substance protein A | VC_0642 | Vibrio cholerae | ||||
67 |
Q5QTY7_IDILO (Q5QTY7) |
4e-20 | 101 | 36% | Transcription elongation factor NusA | nusA IL0969 |
Idiomarina loihiensis | ||||
68 |
C3NUN9_VIBCJ (C3NUN9) |
4e-20 | 101 | 37% | Transcription termination protein NusA | VCD_003769 | Vibrio cholerae serotype O1 (strain MJ-1236) | ||||
69 |
C3LSP7_VIBCM (C3LSP7) |
4e-20 | 101 | 37% | N utilization substance protein A | nusA VCM66_0600 |
Vibrio cholerae serotype O1 (strain M66-2) | ||||
70 |
A5F925_VIBC3 (A5F925) |
4e-20 | 101 | 37% | N utilization substance protein A | nusA VC0395_A0173 VC395_0659 |
Vibrio cholerae serotype O1 (strain ATCC 39541 / Ogawa 395 / O395) | ||||
71 |
D7HRL6_VIBCH (D7HRL6) |
4e-20 | 101 | 37% | Transcription elongation factor NusA | A53_03930 | Vibrio cholerae MAK 757 | ||||
72 |
D7HD26_VIBCH (D7HD26) |
4e-20 | 101 | 37% | N utilization substance protein A | VCRC385_03333 | Vibrio cholerae RC385 | ||||
73 |
D0HNK0_VIBCH (D0HNK0) |
4e-20 | 101 | 37% | Transcription termination protein NusA | VIG_001338 | Vibrio cholerae INDRE 91/1 | ||||
74 |
D0H9J5_VIBCH (D0H9J5) |
4e-20 | 101 | 37% | Transcription termination protein NusA | VIJ_003202 | Vibrio cholerae RC27 | ||||
75 |
C6YJP0_VIBCH (C6YJP0) |
4e-20 | 101 | 37% | Putative uncharacterized protein | VchoM_03022 | Vibrio cholerae MO10 | ||||
76 |
C6RUM4_VIBCH (C6RUM4) |
4e-20 | 101 | 37% | Transcription termination protein NusA | VCH_000450 | Vibrio cholerae CIRS101 | ||||
77 |
C2JAJ7_VIBCH (C2JAJ7) |
4e-20 | 101 | 37% | Transcription termination protein NusA | VCF_000947 | Vibrio cholerae BX 330286 | ||||
78 |
C2IJV1_VIBCH (C2IJV1) |
4e-20 | 101 | 37% | Transcription termination protein NusA | VCC_003592 | Vibrio cholerae RC9 | ||||
79 |
A6ACR9_VIBCH (A6ACR9) |
4e-20 | 101 | 37% | N utilization substance protein A | nusA A59_0689 |
Vibrio cholerae 623-39 | ||||
80 |
A3H049_VIBCH (A3H049) |
4e-20 | 101 | 37% | N utilization substance protein A Transcription termination protein NusA |
nusA A5E_0702 VCE_000631 |
Vibrio cholerae B33 | ||||
81 |
A3GP82_VIBCH (A3GP82) |
4e-20 | 101 | 37% | N utilization substance protein A | nusA A5C_0663 |
Vibrio cholerae NCTC 8457 | ||||
82 |
A2PT75_VIBCH (A2PT75) |
4e-20 | 101 | 37% | N utilization substance protein A | nusA A51_B0618 |
Vibrio cholerae MZO-3 | ||||
83 |
A1EPE2_VIBCH (A1EPE2) |
4e-20 | 101 | 37% | N utilization substance protein A | nusA VCV52_0608 |
Vibrio cholerae V52 | ||||
84 |
A6A575_VIBCH (A6A575) |
4e-20 | 101 | 37% | N utilization substance protein A | nusA A5A_0628 |
Vibrio cholerae MZO-2 | ||||
85 |
Q0AK71_MARMM (Q0AK71) |
4e-20 | 101 | 38% | NusA antitermination factor | Mmar10_3041 | Maricaulis maris (strain MCS10) | ||||
86 |
E3BQH4_9VIBR (E3BQH4) |
4e-20 | 101 | 36% | Transcription elongation factor NusA | nusA VIBC2010_19050 |
Vibrio caribbenthicus ATCC BAA-2122 | ||||
87 |
F4DA35_AERVB (F4DA35) |
4e-20 | 101 | 37% | Transcription elongation factor NusA | B565_3189 | Aeromonas veronii (strain B565) | ||||
88 |
F0NSE5_LACHH (F0NSE5) |
4e-20 | 101 | 40% | Transcription elongation factor NusA | nusA LBHH_0813 |
Lactobacillus helveticus (strain H10) | ||||
89 |
Q8D2X5_WIGBR (Q8D2X5) |
4e-20 | 101 | 36% | NusA protein | nusA WIGBR2270 |
Wigglesworthia glossinidia brevipalpis | ||||
90 |
A0KNE4_AERHH (A0KNE4) |
4e-20 | 101 | 37% | Transcription elongation protein NusA | AHA_3304 | Aeromonas hydrophila subsp. hydrophila (strain ATCC 7966 / NCIB 9240) | ||||
91 |
D4DY22_SEROD (D4DY22) |
5e-20 | 101 | 36% | N utilization substance A | nusA HMPREF0758_0805 |
Serratia odorifera DSM 4582 | ||||
92 |
E1SSS3_FERBD (E1SSS3) |
6e-20 | 101 | 34% | NusA antitermination factor | Fbal_2875 | Ferrimonas balearica (strain DSM 9799 / CCM 4581 / PAT) | ||||
93 |
C9P1A6_VIBME (C9P1A6) |
6e-20 | 101 | 36% | Transcription termination protein NusA | VIB_000253 | Vibrio metschnikovii CIP 69.14 | ||||
94 |
C2HQ38_LACAC (C2HQ38) |
6e-20 | 101 | 39% | Transcription elongation factor NusA | nusA HMPREF0492_1642 |
Lactobacillus acidophilus ATCC 4796 | ||||
95 |
E4SUX0_LACDN (E4SUX0) |
6e-20 | 101 | 39% | Transcription elongation factor NusA | nusA LDBND_1278 |
Lactobacillus delbrueckii subsp. bulgaricus (strain ND02) | ||||
96 |
F0HTS7_LACDL (F0HTS7) |
6e-20 | 101 | 39% | N utilization substance protein A | nusA HMPREF5505_0323 |
Lactobacillus delbrueckii subsp. lactis DSM 20072 | ||||
97 |
B7J4D3_ACIF2 (B7J4D3) |
7e-20 | 100 | 38% | Transcription termination factor NusA | nusA AFE_0390 |
Acidithiobacillus ferrooxidans (strain ATCC 23270 / DSM 14882 / NCIB 8455) Ferrobacillus ferrooxidans (strain ATCC 23270) |
||||
98 |
B5EMC9_ACIF5 (B5EMC9) |
7e-20 | 100 | 38% | NusA antitermination factor | Lferr_0554 | Acidithiobacillus ferrooxidans (strain ATCC 53993) Leptospirillum ferrooxidans (ATCC 53993) |
||||
99 |
Q5FJN3_LACAC (Q5FJN3) |
7e-20 | 100 | 39% | Transcription termination-antitermination factor | nusA LBA1259 |
Lactobacillus acidophilus | ||||
100 |
D8FQ18_LACDE (D8FQ18) |
7e-20 | 100 | 39% | Transcription termination factor NusA | nusA HMPREF9264_0265 |
Lactobacillus delbrueckii subsp. bulgaricus PB2003/044-T3-4 |
accession | DB | alignment | Evalue | Score | Ident. | link | information | pubmed | |||
---|---|---|---|---|---|---|---|---|---|---|---|
1 |
Q6MZ96_MYCUA (Q6MZ96) |
2e-99 | 365 | 100% |
|
| |||||
2 |
B6CLQ1_MYCMR (B6CLQ1) |
3e-97 | 357 | 98% |
|
| |||||
3 |
B6CLU9_9MYCO (B6CLU9) |
1e-90 | 335 | 98% |
|
| |||||
6 |
Q4FVL6_PSYA2 (Q4FVL6) |
1e-21 | 106 | 38% |
|
| |||||
9 |
D5V8Y7_MORCR (D5V8Y7) |
3e-21 | 105 | 38% |
|
| |||||
10 |
F1XHI1_MORCA (F1XHI1) |
3e-21 | 105 | 38% |
|
| |||||
11 |
F1XC11_MORCA (F1XC11) |
3e-21 | 105 | 38% |
|
| |||||
12 |
F1X7F2_MORCA (F1X7F2) |
3e-21 | 105 | 38% |
|
| |||||
13 |
F1X0E7_MORCA (F1X0E7) |
3e-21 | 105 | 38% |
|
| |||||
14 |
F1WS91_MORCA (F1WS91) |
3e-21 | 105 | 38% |
|
| |||||
15 |
F1WM56_MORCA (F1WM56) |
3e-21 | 105 | 38% |
|
| |||||
16 |
F1WGE6_MORCA (F1WGE6) |
3e-21 | 105 | 38% |
|
| |||||
17 |
F1WDD5_MORCA (F1WDD5) |
3e-21 | 105 | 38% |
|
| |||||
18 |
F1WAN5_MORCA (F1WAN5) |
3e-21 | 105 | 38% |
|
| |||||
19 |
F1VR75_MORCA (F1VR75) |
3e-21 | 105 | 38% |
|
| |||||
20 |
Q9HV54_PSEAE (Q9HV54) |
3e-21 | 105 | 38% |
|
| |||||
21 |
Q02FS7_PSEAB (Q02FS7) |
3e-21 | 105 | 38% |
|
| |||||
22 |
B7V1F7_PSEA8 (B7V1F7) |
3e-21 | 105 | 38% |
|
| |||||
26 |
E3A033_PSEAE (E3A033) |
3e-21 | 105 | 38% |
|
| |||||
27 |
A3LK13_PSEAE (A3LK13) |
3e-21 | 105 | 38% |
|
| |||||
28 |
A3L3D0_PSEAE (A3L3D0) |
3e-21 | 105 | 38% |
|
| |||||
32 |
F7YM08_VIBAN (F7YM08) |
1e-20 | 103 | 37% |
|
| |||||
35 |
E6RPR6_PSEU9 (E6RPR6) |
1e-20 | 103 | 37% |
|
| |||||
36 |
Q8EHL6_SHEON (Q8EHL6) |
1e-20 | 103 | 36% |
|
| |||||
39 |
Q3IJ54_PSEHT (Q3IJ54) |
2e-20 | 102 | 36% |
|
| |||||
45 |
D0HBP1_VIBMI (D0HBP1) |
3e-20 | 102 | 37% |
|
| |||||
48 |
D0GT04_VIBMI (D0GT04) |
3e-20 | 102 | 37% |
|
| |||||
64 |
F2GAC7_ALTMD (F2GAC7) |
4e-20 | 101 | 37% |
|
| |||||
65 |
D2YBM1_VIBMI (D2YBM1) |
4e-20 | 101 | 37% |
|
| |||||
66 |
Q9KU81_VIBCH (Q9KU81) |
4e-20 | 101 | 37% |
|
| |||||
67 |
Q5QTY7_IDILO (Q5QTY7) |
4e-20 | 101 | 36% |
|
| |||||
68 |
C3NUN9_VIBCJ (C3NUN9) |
4e-20 | 101 | 37% |
|
| |||||
69 |
C3LSP7_VIBCM (C3LSP7) |
4e-20 | 101 | 37% |
|
| |||||
70 |
A5F925_VIBC3 (A5F925) |
4e-20 | 101 | 37% |
|
| |||||
80 |
A3H049_VIBCH (A3H049) |
4e-20 | 101 | 37% |
|
| |||||
87 |
F4DA35_AERVB (F4DA35) |
4e-20 | 101 | 37% |
|
| |||||
88 |
F0NSE5_LACHH (F0NSE5) |
4e-20 | 101 | 40% |
|
| |||||
89 |
Q8D2X5_WIGBR (Q8D2X5) |
4e-20 | 101 | 36% |
|
| |||||
90 |
A0KNE4_AERHH (A0KNE4) |
4e-20 | 101 | 37% |
|
| |||||
92 |
E1SSS3_FERBD (E1SSS3) |
6e-20 | 101 | 34% |
|
| |||||
97 |
B7J4D3_ACIF2 (B7J4D3) |
7e-20 | 100 | 38% |
|
| |||||
99 |
Q5FJN3_LACAC (Q5FJN3) |
7e-20 | 100 | 39% |
|
|